Covid: Glenmark gets DCGI nod for favipiravir drug

IndiaTimes Friday, 19 June 2020 ()
Drug firm Glenmark Pharmaceuticals on Friday said it has received approval from the Indian drug regulator to launch oral antiviral drug favipiravir for treatment of mild to moderate Covid-19 patients in the country. It is for restricted emergency use in India. Restricted use entails responsible medication use where every patient must have signed informed consent.
0
shares
 
Video credit: KTNV Channel 13 Las Vegas - Published
News video: Remdesivir will be tested on children with COVID-19

Remdesivir will be tested on children with COVID-19 00:21

 A drug that has shown positive results in treating adult coronavirus patients is now being tested on children. Remdesivir will be given to children with moderate to severe cases of COVID-19.